Search results
Results from the WOW.Com Content Network
Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic, fat-soluble, S-acyl derivative of thiamine (vitamin B1) that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in late 1950s in Japan.
Acceptable daily intake or ADI is a measure of the amount of a specific substance (originally applied for a food additive, later also for a residue of a veterinary drug or pesticide) in food or drinking water that can be ingested (orally) daily over a lifetime without an appreciable health risk. [1]
As of October 2018, this study published in 2016 is still the most recent human study about taking oral Benfotiamine for a long time. 300mg/day benfotiamine given to Alzheimer patients for 18 months. No other doses were tested so it is impossible to know the optimal dose yet. Impressive benefits, but only 5 humans participated in the study!
The Dietary Reference Intake (DRI) is a system of nutrition recommendations from the National Academy of Medicine (NAM) [a] of the National Academies (United States). [1] It was introduced in 1997 in order to broaden the existing guidelines known as Recommended Dietary Allowances (RDAs, see below).
This page was last edited on 1 February 2024, at 10:05 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
The therapeutic index (TI; also referred to as therapeutic ratio) is a quantitative measurement of the relative safety of a drug with regard to risk of overdose.It is a comparison of the amount of a therapeutic agent that causes toxicity to the amount that causes the therapeutic effect. [1]
If the literature recommends generally increasing from initial to maximum dose provided it is tolerated, pick the maximum dose. If the literature recommends only increasing from an initial dose if not sufficiently effective, pick the minimum dose. If there is no guidance then pick the mid point between the dose range extremes.
In 2019, a systematic review and meta-analysis examining the relationship between ‘maternal multivitamin supplementation’ and children being diagnosed with autism spectrum disorder (ASD) was published in Nutritional Research. The research was conducted in the previous year and involved using the ‘random effects’ model on 9 independent ...